Adicet Bio Company

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
Technology:
Cell-based gene therapy
Industry:
Longevity, Private
Headquarters:
Redwood City, California, United States
Founded Date:
2014-01-01
Employees Number:
101-250
Investors Number:
7
Total Funding:
145625000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-08-08
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership